| Christopher Bransby Zachary, MD | |
|
1 Medical Plz, Irvine, CA 92697-0001 | |
| (949) 824-5515 | |
| (949) 824-7454 |
| Full Name | Christopher Bransby Zachary |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 50 Years |
| Location | 1 Medical Plz, Irvine, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013943836 | NPI | - | NPPES |
| 00C500740 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | C500740 (California) | Secondary |
| 207NS0135X | Dermatology - Procedural Dermatology | C500740 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uci Department Of Dermatology | 7113920992 | 25 |
News Archive
Henry Ford Hospital dermatology researchers are urging caution about using claims data for identifying nonmelanoma skin cancer, suggesting that the commonly used method, which previously had not been validated, may be unreliable.
New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the body's own insulin cells.
Patients with ulcerative colitis have higher rates of sick leave or disability pension than the general population, show findings published in Gastroenterology.
Oncothyreon Inc. and Array BioPharma Inc. today announced that they will collaborate to develop and commercialize ARRY-380, an orally active, reversible and selective small-molecule HER2 inhibitor.
› Verified 5 days ago
| Entity Name | Uci Department Of Dermatology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518916527 PECOS PAC ID: 7113920992 Enrollment ID: O20060816000496 |
News Archive
Henry Ford Hospital dermatology researchers are urging caution about using claims data for identifying nonmelanoma skin cancer, suggesting that the commonly used method, which previously had not been validated, may be unreliable.
New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the body's own insulin cells.
Patients with ulcerative colitis have higher rates of sick leave or disability pension than the general population, show findings published in Gastroenterology.
Oncothyreon Inc. and Array BioPharma Inc. today announced that they will collaborate to develop and commercialize ARRY-380, an orally active, reversible and selective small-molecule HER2 inhibitor.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Bransby Zachary, MD 101 The City Dr S, Rt 81, Bldg 53, Room 205d, Orange, CA 92868-3201 Ph: (714) 456-5131 | Christopher Bransby Zachary, MD 1 Medical Plz, Irvine, CA 92697-0001 Ph: (949) 824-5515 |
News Archive
Henry Ford Hospital dermatology researchers are urging caution about using claims data for identifying nonmelanoma skin cancer, suggesting that the commonly used method, which previously had not been validated, may be unreliable.
New research shows that it is possible to predict the development of type 1 diabetes. By measuring the presence of autoantibodies in the blood, it is possible to detect whether the immune system has begun to break down the body's own insulin cells.
Patients with ulcerative colitis have higher rates of sick leave or disability pension than the general population, show findings published in Gastroenterology.
Oncothyreon Inc. and Array BioPharma Inc. today announced that they will collaborate to develop and commercialize ARRY-380, an orally active, reversible and selective small-molecule HER2 inhibitor.
› Verified 5 days ago
Dr. Marit Kay Kreidel, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6 Willard, Dept Of Dermatology, Irvine, CA 92604 Phone: 949-262-5780 | |
Justin David Arnold, MD Dermatology Medicare: Medicare Enrolled Practice Location: Department Of Dermatology Administrative Office, 118 Medical Surge I, Irvine, CA 92697 Phone: 949-824-5515 | |
Gary Cheukman Lee, M.D. , PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4980 Barranca Pkwy Ste 202, Irvine, CA 92604 Phone: 949-733-1336 Fax: 949-733-3387 | |
Dr. Marjon Vatanchi, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6865 Alton Pkwy Ste 210, Irvine, CA 92618 Phone: 949-800-8551 Fax: 949-800-8090 | |
Dr. Sogol Saghari, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 113 Waterworks Way Ste 235, Irvine, CA 92618 Phone: 949-679-6564 Fax: 949-679-6554 | |
Jessica Shiu, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 118 Medical Surge 1, Irvine, CA 92697 Phone: 949-824-4405 |